理解后新冠时代美国的疫苗意愿:关键决定因素与人口学差异
2024年一项包含2352名参与者的在线调查采用离散选择实验,探讨假想疫情下影响疫苗接种意愿的因素。结果显示,疫苗意愿与疫苗高有效性和安全性相关,高费用降低接种意愿;外圈社交网络接种率较高可提升意愿,但在疾病传播慢且死亡率高时例外;疾病死亡率高时有效性优先于安全性;既往新冠经历与更高接种意愿相关。
要点
- 疫苗高有效性和安全性提升接种意愿,高费用降低接种意愿。
- 外圈社交网络接种率较高可提升意愿,但疾病传播慢且死亡率高时例外。
- 疾病死亡率高时疫苗有效性优先于安全性,既往新冠经历与更高意愿相关。
核心结论
- 疫苗意愿与疫苗高有效性和安全性相关,高费用降低意愿;外圈网络接种率较高提升意愿,但疾病传播慢且死亡率高时例外;疾病死亡率高时有效性优先于安全性;既往新冠经历与更高接种意愿相关。
研究设计与样本
- 2024年在线调查,共2352名参与者完成,采用离散选择实验及条件logit回归模型和逻辑回归模型分析。
主要发现
- 样本中45.7%为60岁及以上,60.4%为女性,约70%至少高中学历,73%居住在城市。
- 疫苗意愿与疫苗高有效性和安全性相关,较高费用降低接种意愿。
- 外圈网络接种率较高提升意愿,但疾病传播慢且死亡率高时例外。
- 疾病死亡率高时,疫苗有效性优先于安全性。
- 意愿随人口学及其他个体特征变化,既往新冠经历与更高接种意愿相关。
临床怎么用
- 作者认为,为促进未来疫情期间疫苗接种,宣传活动在高风险情境下可强调疫苗有效性,在低风险情境下强调安全性,并针对外圈社交网络及采用文化适配的外展活动以应对不信任。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The COVID-19 vaccine played a key role in ending the pandemic and reshaped public attitudes-some gained trust due to its rapid success, while others became more hesitant. Understanding what drives vaccine uptake, especially in diverse populations, is vital for future public health efforts. In 2024, an online survey with 2352 participants used discrete choice experiments to explore factors influencing willingness to vaccinate during a hypothetical epidemic. Participants were asked if they would like to uptake a vaccine during a hypothetical epidemic under conditions varied by the infectious disease's contagiousness and mortality; the effectiveness, safety, and price of the vaccine; and vaccination rates among inner and outer social circles. Participants were also asked about demographics, health conditions, social support, personal impact of the COVID-19 pandemic, and neighborhood characteristics. Conditional logit regression models and logistic regression models were used to examine how vaccine willingness is associated with various characteristics. A total of 2352 participants completed the online survey. In this sample, 45.7 % were 60 + years old; 60.4 % were females. Approximately 70 % had at least a high school education, and 73 % lived in urban areas. The results indicate that vaccine uptake willingness is associated with the high effectiveness and safety of a vaccine, while higher costs of vaccine deter uptake. Greater vaccination rates in outer networks boost willingness, except when the disease spreads slowly but has high mortality. When the infectious disease has high mortality, the vaccine's effectiveness is prioritized over safety. Willingness also varies by demographics and other individual characteristics, with prior COVID-19 experience associated with higher willingness to vaccine uptake. To promote vaccine uptake for future epidemics, campaigns may emphasize a vaccine's effectiveness in high-risk situations and safety in low-risk ones, target outer social networks, and use culturally tailored outreach to address mistrust.
引用
- Yang Y, Jin SW, Lee S, et al. Understanding vaccine willingness in post-COVID America: Key determinants and demographic differences. Vaccine. 2025. PMID: 40945178. doi:10.1016/j.vaccine.2025.127740
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。